GNMX
Aevi Genomic Medicine Inc
GNMX
GNMX
Delisted
GNMX was delisted on the 3rd of February, 2020.
56 hedge funds and large institutions have $59.4M invested in Aevi Genomic Medicine Inc in 2016 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
56
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.54M | |
| 2 | +$738K | |
| 3 | +$244K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$231K |
| 5 |
State Street
Boston,
Massachusetts
|
+$156K |
Top Sellers
| 1 | -$2.17M | |
| 2 | -$465K | |
| 3 | -$391K | |
| 4 |
Millennium Management
New York
|
-$196K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$141K |